American Journal of Ophthalmology
Volume 143, Issue 4 , Pages 584-595.e2 , April 2007

Adult Retinal Pigment Epithelial Transplantation in Exudative Age-related Macular Degeneration

  • Tongalp H. Tezel

      Affiliations

    • Department of Ophthalmology & Visual Sciences, Kentucky Lions Eye Center, University of Louisville School of Medicine, Louisville, Kentucky
    • ,
  • Lucian V. Del Priore

      Affiliations

    • The Edward S. Harkness Eye Institute, Department of Ophthalmology, Columbia University, New York, New York
    • ,
  • Adam S. Berger

      Affiliations

    • Vitreous and Retina Consultants, PA, Winter Haven, Florida.
    • ,
  • Henry J. Kaplan

      Affiliations

    • Department of Ophthalmology & Visual Sciences, Kentucky Lions Eye Center, University of Louisville School of Medicine, Louisville, Kentucky
    • Corresponding Author InformationInquiries to Henry J. Kaplan, Department of Ophthalmology and Visual Sciences, 301 E. Muhammad Ali Blvd., Louisville, KY 40202

,Accepted 11 December 2006.

References 

  1. West SK. Looking forward to 20/20: a focus on the epidemiology of eye diseases. Epidemiol Rev. 2000;22:64–70
  2. Pieramici DJ, Bressler SB, Koester JM, Bressler NM. Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Veteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No. 4. Arch Ophthalmol. 2006;124:660–664
  3. Stevenson MR, Hart PM, Chakravarthy U, et al. Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS Report No. 2. Br J Ophthalmol. 2005;89:1045–1051
  4. Mruthyunjaya P, Stinnett SS, Toth CA. Impact of fluorescein angiographic characteristics of macular lesions on outcomes after macular translocation 360 degrees surgery in eyes with age-related macular degeneration. Retina. 2005;25:597–607
  5. Poliner LS, Tornambe PE, Michelson PE, Heitzmann JG. Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration. Ophthalmology. 1993;100:1417–1424
  6. Ciardella AP, Donsoff IM, Guyer DR, et al. Antiangiogenesis agents. Ophthalmol Clin North Am. 2002;15:453–458
  7. Slakter JS, Bochow TW, D’Amico DJ, et al. Anecortave Acetate Clinical Study Group Anecortave acetate (15 milligrams) vs photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. Ophthalmology. 2006;113:3–13
  8. Jonas JB, Spandau UH, Kamppeter BA, et al. Duration of the effect of intravitreal triamcinolone acetonide in eyes with exudative age-related macular degeneration. J Ocul Pharmacol Ther. 2006;22:194–199
  9. Gragoudas ES, Adamis AP, Cunningham ET, et al. Pegaptanib for neovascular age-related macular degeneration. New Engl J Med. 2004;351:2805–2816
  10. Tolentino MJ, Brucker AJ, Fosnot J, et al. Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization. Retina. 2004;24:660
  11. Brown DM, Kaier PK, Michels M, et al. ANCHOR Study Group Ranibizumab vs verteporfin for neovascular age-related macular degeneration. New Engl J Med. 2006;355:1432–1444
  12. Heier JS, Boyer DS, Ciulla RA, et al. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. Arch Ophthalmol. 2006;124:1532–1542
  13. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005;23:1011–1027
  14. van Wijngaarden P, Coster DJ, Williams KA. Inhibitors of ocular neovascularization: promises and potential problems. JAMA. 2005;293:1509–1513
  15. Tezel TH, Del Priore LV, Flowers BE, et al. Correlation between scanning laser ophthalmoscope microperimetry and anatomic abnormalities in patients with subfoveal neovascularization. Ophthalmology. 1996;103:1829–1836
  16. Berger AS, Kaplan HJ. Clinical experience with the surgical removal of subfoveal neovascular membranes (Short-term postoperative results). Ophthalmology. 1992;99:969–975
  17. Hawkins BS, Bressler NM, Miskala PH, et al. Submacular Surgery Trials (SST) Research Group Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST Report No. 11. Ophthalmology. 2004;111:1967–1980
  18. Grossniklaus HE, Hutchinson AK, Capone A, et al. Clinicopathologic features of surgically excised choroidal neovascular membranes. Ophthalmology. 1994;101:1099–1111
  19. Pollack JS, Del Priore LV, Smith ME, et al. Postoperative abnormalities of the choriocapillaris in exudative age-related macular degeneration. Br J Ophthalmol. 1996;80:314–318
  20. Nasir MA, Sugino I, Zarbin MA. Decreased choriocapillaris perfusion following surgical excision of choroidal neovascular membranes in age-related macular degeneration. Br J Ophthalmol. 1997;81:481–489
  21. Castellarin AA, Nasir M, Sugino IK, Zarbin MA. Progressive presumed choriocapillaris atrophy after surgery for age-related macular degeneration. Retina. 1998;18:143–149
  22. Del Priore LV, Kaplan HJ, Silverman MS, et al. Experimental and surgical aspects of retinal pigment epithelial cell transplantation. Eur J Implant Ref Surg. 1993;5:128–132
  23. Algvere PV, Berglin L, Gouras P, Sheng Y. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol. 1994;232:707–716
  24. Algvere PV, Berglin L, Gouras P, et al. Transplantation of RPE in age-related macular degeneration: observations in disciform lesions and dry RPE atrophy. Graefes Arch Clin Exp Ophthalmol. 1997;235:149–158
  25. Algvere PV, Gouras P, Dafgard Kopp E. Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD. Eur J Ophthalmol. 1999;9:217–230
  26. Weisz JM, Humayun MS, De Juan E, et al. Allogenic fetal retinal pigment epithelial cell transplant in a patient with geographic atrophy. Retina. 1999;19:540–545
  27. Binder S, Krebs I, Hilgers RD, et al. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci. 2004;45:4151–4160
  28. van Meurs JC, ter Averst E, Hofland LJ, et al. Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes. Br J Ophthalmol. 2004;88:110–113
  29. Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Opt. 1976;53:740–745
  30. Chamberlin JA, Bressler NM, Bressler SB, et al. The Macular Photocoagulation Study Group The use of fundus photographs and fluorescein angiograms in the identification and treatment of choroidal neovascularization in the Macular Photocoagulation Study. Ophthalmology. 1989;96:1526–1534
  31. Tezel TH, Del Priore LV, Kaplan HJ. Harvest and storage of adult human retinal pigment epithelial sheets. Curr Eye Res. 1997;16:802–809
  32. Del Priore LV, Kaplan HJ, Tezel TH, et al. Retinal pigment epithelial cell transplantation after subfoveal membranectomy in age-related macular degeneration: clinicopathologic correlation. Am J Ophthalmol. 2001;131:472–480
  33. Almond PS, Matas AJ, Gillingham K, et al. Pediatric renal transplants—results with sequential immunosuppression. Transplantation. 1992;53:46–51
  34. Daniel W. In: 8th edn.. Biostatistics. A foundation for analysis in the health sciences. 8:New York, New York: John Wiley & Sons; 2004;p. 303–409
  35. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration (Results of a randomized clinical trial). Arch Ophthalmol. 1991;109:1220–1231
  36. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration (Results of a randomized clinical trial). Arch Ophthalmol. 1991;109:1232–1241
  37. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of two randomized clinical trials—TAP report. Arch Ophthalmol. 1999;117:1329–1345
  38. Jonas JB, Degenring RF, Kreissig I, et al. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide: a prospective comparative nonrandomized study. Eye. 2005;19:163–170
  39. Nelson ML, Tennant MT, Sivalingam A, et al. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina. 2003;23:686–691
  40. Gillies MC, Simpson JM, Billson FA, et al. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol. 2004;122:336–340
  41. Tezel TH, Bora NS, Kaplan HJ. Pathogenesis of age-related macular degeneration. Trends Mol Med. 2004;10:417–420
  42. Kim SY, Sadda S, Pearlman J, et al. Morphometric analysis of the macula in eyes with disciform age-related macular degeneration. Retina. 2002;22:471–477
  43. Joussen AM, Heussen FMA, Joeres S, et al. Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol. 2006;142:17–30
  44. Berger AS, Kaplan HJ. Clinical experience with the surgical removal of subfoveal neovascular membranes: short-term postoperative results. Ophthalmology. 1992;99:969–976
  45. Lambert HM, Capone A, Aaberg TM, et al. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1992;113:257–262
  46. Del Priore LV, Kaplan HJ, Berger AS. Retinal pigment epithelial transplantation in the management of subfoveal choroidal neovascularization. Semin Ophthalmol. 1997;12:45–55
  47. Akduman L, Del Priore LV, Desai VN, et al. Perfusion of the subfoveal choriocapillaris affects visual recovery after submacular surgery in presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 1997;123:90–96
  48. Tezel TH, Kaplan HJ, Del Priore LV. Fate of human retinal pigment epithelial cells seeded onto layers of human Bruch’s membrane. Invest Ophthalmol Vis Sci. 1999;40:467–476
  49. Tsukahara I, Ninomiya S, Castellarin A, et al. Early attachment of uncultured retinal pigment epithelium from aged donors onto Bruch’s membrane explants. Exp Eye Res. 2002;74:255–266
  50. Gullapalli VK, Sugino IK, van Patten Y, et al. Impaired RPE survival on aged submacular human Bruch’s membrane. Exp Eye Res. 2005;80:235–248
  51. Peyman GA, Blinder KJ, Paris CL, et al. A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring. Ophthalmic Surg. 1991;22:102–108
  52. Jiang LQ, Jorquera M, Streilein JW. Immunologic consequences of intraocular implantation of retinal pigment epithelial allografts. Exp Eye Res. 1994;58:719–728
  53. Ye J, Wang HM, Ogden TE, Ryan SJ. Allotransplantation of rabbit retinal pigment epithelial cells double-labeled with 5-bromodeoxyuridine (BrdU) and natural pigment. Curr Eye Res. 1993;12:629–639
  54. Streilein JW, Ma N, Wenkel H, et al. Immunobiology and privilege of neuronal retina and pigment epithelium transplants. Vision Res. 2002;42:487–495
  55. Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration?. Graefes Arch Clin Exp Ophthalmol. 1993;231:635–641
  56. Pieramici DJ, De Juan E, Fujii GY, et al. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol. 2000;130:419–428
  57. Green WR, Enger C. Age-related macular degeneration histopathologic studies (The 1992 Lorenz E. Zimmerman Lecture). Ophthalmology. 1993;100:1519–1535
  58. Berger AS, Conway M, De Priore LV, et al. Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis. Arch Ophthalmol. 1997;115:991–996
  59. Tezel TH, Del Priore LV. Repopulation of different layers of host human Bruch’s membrane by retinal pigment epithelial cell grafts. Invest Ophthalmol Vis Sci. 1999;40:767–774
  60. Tezel TH, Del Priore LV, Kaplan HJ. Reengineering of aged Bruch’s membrane to enhance retinal pigment epithelium repopulation. Invest Ophthalmol Vis Sci. 2004;45:3337–3348
  61. Berger AS, Tezel TH, Del Priore LV, Kaplan HJ. Photoreceptor transplantation in retinitis pigmentosa: short-term follow-up. Ophthalmology. 2003;110:383–391
  62. Akduman L, Karavellas MP, MacDonald JC, et al. Macular translocation with retinotomy and retinal rotation for exudative age-related macular degeneration. Retina. 1999;19:418–423
  63. Wolf S, Lappas A, Weinberger AW, Kirchhof B. Macular translocation for surgical management of subfoveal choroidal neovascularizations in patients with AMD: first results. Graefes Arch Clin Exp Ophthalmol. 1999;237:51–57
  64. Bressler NM, Bressler SB, Childs AL, et al. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST Report No. 13. Ophthalmology. 2004;111:1993–2006
  65. Dutt K, Waldrep JC, Kaplan HJ, et al. In vitro phenotypic and functional characterization of human pigment epithelial cell lines. Curr Eye Res. 1989;8:435–440
  66. Zavazava N, Halene M, Westphal E, et al. Expression of MHC class I and II molecules by cadaver retinal pigment epithelium cells: optimization of post-mortem HLA typing. Clin Exp Immunol. 1991;84:163–166
  67. Ma A, Chen H. Small molecule immunosuppressive agents in experimental and clinical transplantation. Curr Drug Targets Cardiovasc Haematol Disord. 2002;2:57–71

 See accompanying Editorial on page 681.

PII: S0002-9394(06)01415-2

doi: 10.1016/j.ajo.2006.12.007

American Journal of Ophthalmology
Volume 143, Issue 4 , Pages 584-595.e2 , April 2007

Article Tools

* Image Usage & Resolution